Brian Goff
Board Member
Agios Pharmaceuticals, Inc. (AGIO)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Agios Pharmaceuticals, Inc. (AGIO) | Chief Executive Officer | $846,864 | $5,370,389 |
| 2024 | Agios Pharmaceuticals, Inc. (AGIO) | Chief Executive Officer | $822,198 | $6,776,359 |
| 2023 | Agios Pharmaceuticals, Inc. (AGIO) | Chief Executive Officer | $798,250 | $3,416,453 |
| 2022 | Agios Pharmaceuticals, Inc. (AGIO) | Chief Executive Officer | $308,239 | $11,744,447 |
| 2021 | Agios Pharmaceuticals, Inc. (AGIO) | Chief Executive Officer | — | — |
| 2020 | Agios Pharmaceuticals, Inc. (AGIO) | Chief Executive Officer | — | — |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.